Oncofertility tech gives young cancer patients a path to parenthood
A growing field called oncofertility helps younger cancer patients preserve fertility alongside treatment, using methods such as egg freezing and ovarian tissue preservation; cases like Jenilee Crowley, who paused hormone therapy to freeze embryos and welcome a son, illustrate both the possibilities and the time-sensitive challenges of fertility preservation. Costs can reach about $20,000 without insurance, and coverage varies by state, though several New England states have enacted laws to expand benefits and nonprofits like Worth the Wait help with storage costs. New research from Dana-Farber suggests that delaying pregnancy by pausing therapy does not necessarily raise recurrence risk, offering survivors a viable path to biological children after cancer.
